Parini Michael — SEC insider filings
SEC reporting owner CIK 1661567. 10 insider filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2020-08-10 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 26 legs across 8 filings — 21,145 shares, $4,573,776 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 4,666 shares @ $211.83 ($988,399) in VERTEX PHARMACEUTICALS INC / MA, filed 2021-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Adm, Leg & BD Off | 9 | — | 26 legs · 21,145 sh · $4,573,776 | 14 |
| BIOGEN INC. (BIIB) | Chief Legal Officer | 1 | — | — | 1 |
Insider filings — Parini Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 7,405 (derivative) @ $0 | EDGAR |
| 2021-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,416 @ $217.57 · Sale (S): 646 @ $211.58 · Sale (S): 1,348 @ $213.04 · Sale (S): 680 @ $214.28 · Sale (S): 354 @ $216.26 | EDGAR |
| 2021-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 6,240 @ $211.75 · Sale (S): 1,007 @ $210.08 · Sale (S): 4,666 @ $211.83 · Sale (S): 1,952 @ $212.56 · Sale (S): 200 @ $213.45 | EDGAR |
| 2021-02-16 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,818 @ $210.43 · Sale (S): 300 @ $211.21 · Sale (S): 200 @ $211.97 | EDGAR |
| 2021-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,563 @ $214.16 | EDGAR |
| 2021-02-09 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 1,930 @ $86.52 · Sale (S): 1,930 @ $215 · Option exercise (M): 1,930 (derivative) @ $0 | EDGAR |
| 2021-02-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 8,438 @ $0 · Grant/award (A): 10,324 @ $0 · Grant/award (A): 11,627 @ $0 · Option exercise (M): 400 @ $86.52 · Sale (S): 200 @ $215.52 · Sale (S): 100 @ $217 · +2 more | EDGAR |
| 2020-11-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 26 @ $222.52 · Sale (S): 40 @ $223.67 · Sale (S): 25 @ $224.34 | EDGAR |
| 2020-11-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 2,330 @ $86.52 · Sale (S): 630 @ $215.16 · Sale (S): 600 @ $217.20 · Sale (S): 600 @ $218.63 · Sale (S): 300 @ $220.10 · Sale (S): 200 @ $221.25 · +1 more | EDGAR |
| 2020-08-10 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 1,223 @ $155.57 · Sale (S): 490 @ $270.13 · Sale (S): 422 @ $271.45 · Sale (S): 311 @ $272.53 · Option exercise (M): 1,223 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1661567 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs